In the management of an acute asthma exacerbation, which combination of therapies is recommended?

In the management of an acute asthma exacerbation, which combination of therapies is recommended?

• A. SABA alone
• B. SABA with anticholinergic and systemic corticosteroids
• C. Antibiotics plus bronchodilators
• D. Oxygen only

Answer: (B)

In an acute asthma flare, rapid bronchodilation plus anti-inflammatory treatment is essential to open the airways and control the underlying inflammation. A short-acting beta-agonist (SABA) provides quick relief of bronchospasm, which is the immediate need. Adding an anticholinergic medication (ipratropium) contributes additional bronchodilation by inhibiting vagal-mediated bronchoconstriction, and this combination is especially helpful in moderate to severe exacerbations where bronchodilation with just a SABA may be insufficient. Giving systemic corticosteroids—orally or IV—addresses the underlying airway inflammation, speeds recovery, reduces the risk of relapse, and can shorten hospital stay. Oxygen therapy is important if the patient’s oxygen saturation is low, but providing oxygen alone does not treat bronchospasm or inflammation. Antibiotics are not routinely used in typical asthma exacerbations unless there is a concurrent infection or another indication. Therefore, the recommended approach in this scenario is to use a SABA in combination with an anticholinergic and systemic corticosteroids. This combination targets both immediate bronchospasm and the inflammatory process to achieve better control and faster recovery.

In an acute asthma flare, rapid bronchodilation plus anti-inflammatory treatment is essential to open the airways and control the underlying inflammation. A short-acting beta-agonist (SABA) provides quick relief of bronchospasm, which is the immediate need. Adding an anticholinergic medication (ipratropium) contributes additional bronchodilation by inhibiting vagal-mediated bronchoconstriction, and this combination is especially helpful in moderate to severe exacerbations where bronchodilation with just a SABA may be insufficient. Giving systemic corticosteroids—orally or IV—addresses the underlying airway inflammation, speeds recovery, reduces the risk of relapse, and can shorten hospital stay.

Oxygen therapy is important if the patient’s oxygen saturation is low, but providing oxygen alone does not treat bronchospasm or inflammation. Antibiotics are not routinely used in typical asthma exacerbations unless there is a concurrent infection or another indication.

Therefore, the recommended approach in this scenario is to use a SABA in combination with an anticholinergic and systemic corticosteroids. This combination targets both immediate bronchospasm and the inflammatory process to achieve better control and faster recovery.